BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 24890767)

  • 1. The urinary proteome and peptidome of renal cell carcinoma patients: a comparison of different techniques.
    Raimondo F; Corbetta S; Chinello C; Pitto M; Magni F
    Expert Rev Proteomics; 2014 Aug; 11(4):503-14. PubMed ID: 24890767
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Are protease inhibitors required for gel-based proteomics of kidney and urine?
    Havanapan PO; Thongboonkerd V
    J Proteome Res; 2009 Jun; 8(6):3109-17. PubMed ID: 19354301
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential protein profiling of renal cell carcinoma urinary exosomes.
    Raimondo F; Morosi L; Corbetta S; Chinello C; Brambilla P; Della Mina P; Villa A; Albo G; Battaglia C; Bosari S; Magni F; Pitto M
    Mol Biosyst; 2013 Jun; 9(6):1220-33. PubMed ID: 23511837
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mass spectrometry based proteomics in urine biomarker discovery.
    Theodorescu D; Mischak H
    World J Urol; 2007 Oct; 25(5):435-43. PubMed ID: 17703310
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urinary exosomes and diabetic nephropathy: a proteomic approach.
    Raimondo F; Corbetta S; Morosi L; Chinello C; Gianazza E; Castoldi G; Di Gioia C; Bombardi C; Stella A; Battaglia C; Bianchi C; Magni F; Pitto M
    Mol Biosyst; 2013 Jun; 9(6):1139-46. PubMed ID: 23344851
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative membrane proteomics: a technical advancement in the search of renal cell carcinoma biomarkers.
    Raimondo F; Corbetta S; Savoia A; Chinello C; Cazzaniga M; Rocco F; Bosari S; Grasso M; Bovo G; Magni F; Pitto M
    Mol Biosyst; 2015 Jun; 11(6):1708-16. PubMed ID: 25926002
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urinary proteomics.
    González-Buitrago JM; Ferreira L; Lorenzo I
    Clin Chim Acta; 2007 Jan; 375(1-2):49-56. PubMed ID: 16942764
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urinary extracellular microvesicles: isolation methods and prospects for urinary proteome.
    Wang D; Sun W
    Proteomics; 2014 Aug; 14(16):1922-32. PubMed ID: 24962155
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differencial proteome of clear-cell renal cell carcinoma (ccRCC) tissues.
    Vieira de Ribeiro AJ; Sandim V; Ornellas AA; Reis RS; Domont G; Alves G
    Int Braz J Urol; 2013; 39(1):83-94. PubMed ID: 23510786
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of fenofibrate treatment on the low molecular weight urinary proteome of healthy volunteers.
    Foucher C; Schiffer E; Mischak H; Ansquer JC; Wilbraham D
    Proteomics Clin Appl; 2011 Apr; 5(3-4):159-66. PubMed ID: 21360683
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Urinary proteomics: towards biomarker discovery, diagnostics and prognostics.
    Thongboonkerd V
    Mol Biosyst; 2008 Aug; 4(8):810-5. PubMed ID: 18633482
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pro: urine proteomics as a liquid kidney biopsy: no more kidney punctures!
    Mischak H
    Nephrol Dial Transplant; 2015 Apr; 30(4):532-7. PubMed ID: 25801638
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A proteomic glimpse into human ureter proteome.
    Magdeldin S; Hirao Y; Elguoshy A; Xu B; Zhang Y; Fujinaka H; Yamamoto K; Yates JR; Yamamoto T
    Proteomics; 2016 Jan; 16(1):80-4. PubMed ID: 26442468
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proteomics of liquid biopsies: Depicting RCC infiltration into the renal vein by MS analysis of urine and plasma.
    Chinello C; Stella M; Piga I; Smith AJ; Bovo G; Varallo M; Ivanova M; Denti V; Grasso M; Grasso A; Del Puppo M; Zaravinos A; Magni F
    J Proteomics; 2019 Jan; 191():29-37. PubMed ID: 29689304
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of renal cell carcinoma-associated markers via proteome- and other 'ome'-based analyses.
    Seliger B; Lichtenfels R; Kellner R
    Brief Funct Genomic Proteomic; 2003 Oct; 2(3):194-212. PubMed ID: 15239923
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proteome analysis of gelatin-bound urinary proteins from patients with bladder cancers.
    Saito M; Kimoto M; Araki T; Shimada Y; Fujii R; Oofusa K; Hide M; Usui T; Yoshizato K
    Eur Urol; 2005 Nov; 48(5):865-71. PubMed ID: 15964125
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The proteomic landscape of renal tumors.
    Chinello C; L'imperio V; Stella M; Smith AJ; Bovo G; Grasso A; Grasso M; Raimondo F; Pitto M; Pagni F; Magni F
    Expert Rev Proteomics; 2016 Dec; 13(12):1103-1120. PubMed ID: 27748142
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urine 2DE proteome analysis in healthy condition and kidney disease.
    Martin-Lorenzo M; Gonzalez-Calero L; Zubiri I; Diaz-Payno PJ; Sanz-Maroto A; Posada-Ayala M; Ortiz A; Vivanco F; Alvarez-Llamas G
    Electrophoresis; 2014 Sep; 35(18):2634-41. PubMed ID: 24913465
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Investigation of urine proteome in normal humans].
    Dobrokhotov IV; Pastushkova LKh; Larina IM; Nikolaev EN
    Aviakosm Ekolog Med; 2009; 43(3):3-10. PubMed ID: 19711855
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Simple urinary sample preparation for proteomic analysis.
    Khan A; Packer NH
    J Proteome Res; 2006 Oct; 5(10):2824-38. PubMed ID: 17022654
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.